BDBM227709 3-{7-[(trans-4- methylcyclohexyl)methyl]- 6-(2-methylmorpholin-4- yl)-8-[(3r)-3- phenylmorpholin-4-yl]- 7h-purin-2-yl}-1,2,4- oxadiazol-5(4h)-one (mixture of diastereomers)::US9540377, 26.3

SMILES CC1CN(c2nc(-c3noc(=O)[nH]3)nc3nc(N4CCOC[C@H]4c4ccccc4)n(C[C@H]4CC[C@H](C)CC4)c23)CCO1

InChI Key InChIKey=DIIUGXSAATZGPT-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 227709   

TargetE3 ubiquitin-protein ligase Mdm2 [17-125](Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 227709BDBM227709(US9540377, 26.3 | 3-{7-[(trans-4- methylcyclohexyl...)
Affinity DataIC50: 14.5nMT: 2°CAssay Description:An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2018
Entry Details
US Patent